Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 58, Issue 4, 2017, Pages 1109-1119

  Tripathi, Ajai K ^a   Karmakar, Shilpita ^a   Asthana, Abhishek ^a   Ashok, Ajay ^a   Desai, Vilok ^a   Baksi, Shounak ^a   Singh, Neena ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; brain; inflammation; kidney; non transferrin bound iron

Indexed keywords

NON TRANSFERRIN BOUND IRON FE 59; RADIOPHARMACEUTICAL AGENT; TRANSFERRIN FE 59; UNCLASSIFIED DRUG; HEPCIDIN; IRON; IRON-59; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE; TRANSFERRIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN VENTRICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; FEMUR; HEART; IRON OVERLOAD; IRON TRANSPORT; ISOTOPE LABELING; KIDNEY; LIVER; MOUSE; MOUSE MODEL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PANCREAS; PRIORITY JOURNAL; SPLEEN; UPREGULATION; ANIMAL; BRAIN; CARDIAC MUSCLE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TIME FACTOR; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HEPCIDINS; IRON; IRON RADIOISOTOPES; KIDNEY; LIPOPOLYSACCHARIDES; MICE; MYOCARDIUM; TIME FACTORS; TISSUE DISTRIBUTION; TRANSFERRIN;

EID: 85021286117     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-170097     Document Type: Article

References (56)

1. Bartzokis G, Lu PH, Mintz J (2007) Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement 3, 122-125.
2. Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz J (2000) In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 57, 47-53.
3. Ayton S, Faux NG, Bush AI, Alzheimer's Disease Neuroimaging I (2015) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun 6, 6760.
4. Allen RP, Earley CJ (2007) The role of iron in restless legs syndrome. Mov Disord 22(Suppl 18), S440-S448.
5. Youdim MB (2008) Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res 14, 45-56.
6. Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer's disease and Parkinson's disease: Targets for therapeutics. J Neurochem 139(Suppl 1), 179-197.
7. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease:Apilot phase 2 clinical trial. Arch Neurol 60, 1685-1691.
8. Grossi C, Francese S, Casini A, Rosi MC, Luccarini I, Fiorentini A, Gabbiani C, Messori L, Moneti G, Casamenti F (2009) Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 17, 423-440.
9. Engelhardt B, Sorokin L (2009) The blood-brain and the blood-cerebrospinal fluid barriers: Function and dysfunction. Semin Immunopathol 31, 497-511.
10. Milward E, Acikyol B, Bassett B, Williams E, Graham R, Delima R, Trinder D, Olynyk J, Johnstone D (2012) Brain changes in iron loading disorders. In Metal Ions in Neurological Systems, Linert W, Kozlowski H, eds. Springer, pp. 17-29.
11. Bradbury MW (1997) Transport of iron in the blood-braincerebrospinal fluid system. J Neurochem 69, 443-454.
12. Pirpamer L, Hofer E, Gesierich B, De Guio F, Freudenberger P, Seiler S, Duering M, Jouvent E, Duchesnay E, Dichgans M, Ropele S, Schmidt R (2016) Determinants of iron accumulation in the normal aging brain. Neurobiol Aging 43, 149-155.
13. McKie AT, Latunde-Dada GO, Miret S, McGregor JA, Anderson GJ, Vulpe CD, Wrigglesworth JM, Simpson RJ (2002) Molecular evidence for the role of a ferric reductase in iron transport. Biochem Soc Trans 30, 722-724.
14. McCarthy RC, Kosman DJ (2012) Mechanistic analysis of iron accumulation by endothelial cells of the BBB. Biometals 25, 665-675.
15. McCarthy RC, Kosman DJ (2015) Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier. Front Mol Neurosci 8, 31.
16. Bishop GM, Dang TN, Dringen R, Robinson SR (2011) Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res 19, 443-451.
17. Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJ (2002) Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 32(Suppl 1), 9-16.
18. Stefansson BV, Haraldsson B, Nilsson U (2008) Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. Free Radic Biol Med 45, 1302-1307.
19. Dresow B, Petersen D, Fischer R, Nielsen P (2008) Nontransferrin-bound iron in plasma following administration of oral iron drugs. Biometals 21, 273-276.
20. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S (2013) The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 65, 1174-1194.
21. Brissot P, Ropert M, Le Lan C, Loreal O (2012) Nontransferrin bound iron: A key role in iron overload and iron toxicity. Biochim Biophys Acta 1820, 403-410.
22. Sebastiani G, Pantopoulos K (2014) NTBI unveiled by chelatable fluorescent beads. Biochem J 463, e7-e9.
23. Loreal O, Turlin B, Pigeon C, Moisan A, Ropert M, Morice P, Gandon Y, Jouanolle AM, Verin M, Hider RC, Yoshida K, Brissot P (2002) Aceruloplasminemia: New clinical, pathophysiological and therapeutic insights. J Hepatol 36, 851-856.
24. Chakrabarti M, Barlas MN, McCormick SP, Lindahl LS, Lindahl PA (2015) Kinetics of iron import into developing mouse organs determined by a pup-swapping method. J Biol Chem 290, 520-528.
25. Ito S, Ikuta K, Kato D, Lynda A, Shibusa K, Niizeki N, Toki Y, Hatayama M, Yamamoto M, Shindo M, Iizuka N, Kohgo Y, Fujiya M (2016) In vivo behavior of NTBI revealed by automated quantification system. Int J Hematol 104, 175-181.
26. Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC (1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna) 105, 479-488.
27. Moos T, Morgan EH (1998) Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J Neurosci Res 54, 486-494.
28. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J (2005) CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 14, 43-47.
29. Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T (2011) Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci 303, 95-99.
30. Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, Kaplan J (1987) Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: A rodent model for hemochromatosis. Proc Natl Acad Sci U S A 84, 3457-3461.
31. Haldar S, Tripathi A, Qian J, Beserra A, Suda S, McElwee M, Turner J, Hopfer U, Singh N (2015) Prion protein promotes kidney iron uptake via its ferrireductase activity. J Biol Chem 290, 5512-5522.
32. Aydemir TB, Chang SM, Guthrie GJ, Maki AB, Ryu MS, Karabiyik A, Cousins RJ (2012) Zinc transporter ZIP14 functions in hepatic zinc, iron and glucose homeostasis during the innate immune response (endotoxemia). PLoS One 7, e48679.
33. Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, Kidd GJ, Bergmann CC, Stohlman SA, Trapp BD (2012) Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci 32, 11706-11715.
34. Tripathi AK, Singh N (2016) Prion protein-hemin interaction upregulates hemoglobin synthesis: Implications for cerebral hemorrhage and sporadic Creutzfeldt-Jakob disease. J Alzheimers Dis 51, 107-121.
35. Singh A, Mohan ML, Isaac AO, Luo X, Petrak J, Vyoral D, Singh N (2009) Prion protein modulates cellular iron uptake:Anovel function with implications for prion disease pathogenesis. PLoS One 4, e4468.
36. Liu S, Grigoryan MM, Vasilevko V, Sumbria RK, Paganini-Hill A, Cribbs DH, Fisher MJ (2014) Comparative analysis of H&E and Prussian blue staining in a mouse model of cerebral microbleeds. J Histochem Cytochem 62, 767-773.
37. Baksi S, Tripathi AK, Singh N (2016) Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease. Free Radic Biol Med 97, 292-306.
38. Tripathi AK, Haldar S, Qian J, Beserra A, Suda S, Singh A, Hopfer U, Chen SG, Garrick MD, Turner JR, Knutson MD, Singh N (2015) Prion protein functions as a ferrireductase partner for ZIP14 and DMT1. Free Radic Biol Med 84, 322-330.
39. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
40. Wessling-Resnick M (2010) Iron homeostasis and the inflammatory response. Annu Rev Nutr 30, 105-122.
41. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934.
42. Qin L,Wu X, Block ML, LiuY, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462.
43. Puntener U, Booth SG, Perry VH, Teeling JL (2012) Longterm impact of systemic bacterial infection on the cerebral vasculature and microglia. J Neuroinflammation 9, 146.
44. Bodea LG,Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove R, Kaoma T, Muller A, Vallar L, Di Monte DA, Balling R, Neumann H (2014) Neurodegeneration by activation of the microglial complementphagosome pathway. J Neurosci 34, 8546-8556.
45. Ganz T, Nemeth E (2015) Iron homeostasis in host defence and inflammation. Nat Rev Immunol 15, 500-510.
46. Simpson IA, Ponnuru P, Klinger ME, Myers RL, Devraj K, Coe CL, Lubach GR, Carruthers A, Connor JR (2015) A novel model for brain iron uptake: Introducing the concept of regulation. J Cereb Blood Flow Metab 35, 48-57.
47. Martines AM, Masereeuw R, Tjalsma H, Hoenderop JG, Wetzels JF, Swinkels DW (2013) Iron metabolism in the pathogenesis of iron-induced kidney injury. Nat Rev Nephrol 9, 385-398.
48. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ (2006) Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A 103, 13612-13617.
49. Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, Ganz T, Cousins RJ (2005) Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A 102, 6843-6848.
50. Andersen HH, Johnsen KB, Moos T (2014) Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell Mol Life Sci 71, 1607-1622.
51. Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonzalez-Billault C, Nunez MT (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126, 541-549.
52. Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60, 1-12.
53. Canonne-Hergaux F, Gros P (2002) Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int 62, 147-156.
54. Fujishiro H, Yano Y, Takada Y, Tanihara M, Himeno S (2012) Roles of ZIP8, ZIP14, and DMT1 in transport of cadmium and manganese in mouse kidney proximal tubule cells. Metallomics 4, 700-708.
55. Jenkitkasemwong S, Wang CY, Coffey R, Zhang W, Chan A, Biel T, Kim JS, Hojyo S, Fukada T, Knutson MD (2015) SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab 22, 138-150.
56. Singh A, Isaac AO, Luo X, Mohan ML, Cohen ML, Chen F, Kong Q, Bartz J, Singh N (2009) Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog 5, e1000336.